Question

A 58-year-old with type 2 diabetes, UACR 420 mg/g, and eGFR 28 mL/min/1.73 m² (on maximized ACE inhibitor and metformin dose-reduced) asks about kidney protection. Next best disease-modifying therapy?

Accepted Answer

Add basal insulin

Answer

Add a GLP-1 receptor agonist only

Answer

Start an SGLT2 inhibitor

Answer

Switch ACE inhibitor to ARB

Answer

Start thiazolidinedione

Practice question

A 58-year-old with type 2 diabetes, UACR 420 mg/g, and eGFR 28 mL/min/1.73 m² (on maximized ACE inhibitor and metformin dose-reduced) asks about kidney protection. Next best disease-modifying therapy?